From: Outcomes of endoscopic transsphenoidal surgery for Cushing's disease
Pre-operative MRI | D3 0800h serum cortisol (nmol/L) 1st ETSS | Subsequent management | |
---|---|---|---|
1 | Microadenoma | 555 | Second ETSS – in remission, D3 cortisol 41 nmol/L. |
2 | Microadenoma | 306 | Second ETSS – persistent mild hypercortisolemia, D3 cortisol 80 nmol/L. |
3 | Nil visible | 386 | Second ETSS – persistent disease, D3 cortisol 379 nmol/L. Medical therapy with cabergoline and stereotactic radiosurgery. |
4 | Nil visible | 779 | Bilateral adrenalectomy |
5 | Macroadenoma with cavernous sinus invasion | 497 | Medical therapy with metyrapone. Fractionated pituitary radiotherapy |